Thoracic Cancer-期刊论坛，投稿经验-MedSci.cn

[GetPortalCommentsPageByObjectIdResponse(id=1104618, encodeId=c5ee1104618ee, content=什么时候使用柱状图，什么时候使用折线图？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=68, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=71734776539, createdName=MS54455111222, createdTime=Wed Dec 29 14:52:52 CST 2021, time=2021-12-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1104617, encodeId=94ce110461e91, content=为什么期刊要求用三线表/使用三线表的意义何在？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=77, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210511/ddebdec707734c8390a07bd0c1048717/cc11caf5d607430e9f4ca556fed68ab1.jpg, createdBy=2c4d5497888, createdName=msSSSSSD, createdTime=Wed Dec 29 14:52:52 CST 2021, time=2021-12-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=572184, encodeId=0afb5e21844d, content=请问，食管肿瘤偏内科治疗的个案能发这个杂志吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=151, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=28de5119650, createdName=14631f28m76(暂无昵称), createdTime=Wed Jun 12 18:23:00 CST 2019, time=2019-06-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=897408, encodeId=d6a789e40815, content=只能一个通讯作者吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=99, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=76105326500, createdName=148bd578m47暂无昵称, createdTime=Fri Nov 06 21:22:46 CST 2020, time=2020-11-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=590132, encodeId=c321590132ed, content=请问你的文章是基础的还是临床的呀爱睡觉的小妖精uhh 2020-04-30 00:00:00 发表: 已经发表啦，开心, beContent=爱睡觉的小妖精uhh 2020-04-30 00:00:00 发表: 已经发表啦，开心, objectType=tool_impact_factor, channel=null, level=null, likeNumber=133, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/06/21/141c3b405ac632875dc5e2f757c9755d.jpg, createdBy=d8912207664, createdName=1085404196_71099776, createdTime=Sat May 02 00:00:00 CST 2020, time=2020-05-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2159028, encodeId=b8572159028f8, content=审稿速度:1.0 偏重的研究方向：肺癌 经验分享：个案 2天被拒枯了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=41, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=0dad8612290, createdName=ms9000001053108898, createdTime=Fri Sep 22 01:20:26 CST 2023, time=2023-09-22, status=1, ipAttribution=甘肃省), GetPortalCommentsPageByObjectIdResponse(id=2145118, encodeId=71e0214511808, content=最近还收meta分析吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=49, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=16686542389, createdName=ms7000001609282445, createdTime=Tue Jun 27 23:07:03 CST 2023, time=2023-06-27, status=1, ipAttribution=山东省), GetPortalCommentsPageByObjectIdResponse(id=2129414, encodeId=7b422129414fc, content=Submissions will be subject to an APC if accepted and published in the journal: $2750 USD / £1850 GBP / €2500 EUR, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=41, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=81ca5454976, createdName=ms3000001340442240, createdTime=Sun Apr 30 12:52:16 CST 2023, time=2023-04-30, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2117650, encodeId=032e211e650b5, content=审稿速度:1.0 经验分享：我投的生信，做了验证，第二天就拒了，感觉这个杂志应该不好中的，质量不错的。看了一下近一年这个杂志发的生信，大部分好像都是有细胞实验的。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=42, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=99d78274978, createdName=ms3000001126828781, createdTime=Sun Mar 05 09:55:55 CST 2023, time=2023-03-05, status=1, ipAttribution=广西), GetPortalCommentsPageByObjectIdResponse(id=2116294, encodeId=5621211629450, content=偏重的研究方向：肺癌;肿瘤 经验分享：投的meta分析，3天被拒, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20230223/3495061b3fd940bfae63e19d5c634f3e/4aae1a7e9e5c4f4f890a29ff7266640b.jpg, createdBy=0b086152617, createdName=兔兔好运发paper, createdTime=Fri Feb 24 16:06:22 CST 2023, time=2023-02-24, status=1, ipAttribution=四川省)]

2021-12-29 MS54455111222

什么时候使用柱状图，什么时候使用折线图？

68 1

展开1条回复

[GetPortalCommentsPageByObjectIdResponse(id=1104618, encodeId=c5ee1104618ee, content=什么时候使用柱状图，什么时候使用折线图？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=68, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=71734776539, createdName=MS54455111222, createdTime=Wed Dec 29 14:52:52 CST 2021, time=2021-12-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1104617, encodeId=94ce110461e91, content=为什么期刊要求用三线表/使用三线表的意义何在？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=77, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210511/ddebdec707734c8390a07bd0c1048717/cc11caf5d607430e9f4ca556fed68ab1.jpg, createdBy=2c4d5497888, createdName=msSSSSSD, createdTime=Wed Dec 29 14:52:52 CST 2021, time=2021-12-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=572184, encodeId=0afb5e21844d, content=请问，食管肿瘤偏内科治疗的个案能发这个杂志吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=151, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=28de5119650, createdName=14631f28m76(暂无昵称), createdTime=Wed Jun 12 18:23:00 CST 2019, time=2019-06-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=897408, encodeId=d6a789e40815, content=只能一个通讯作者吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=99, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=76105326500, createdName=148bd578m47暂无昵称, createdTime=Fri Nov 06 21:22:46 CST 2020, time=2020-11-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=590132, encodeId=c321590132ed, content=请问你的文章是基础的还是临床的呀爱睡觉的小妖精uhh 2020-04-30 00:00:00 发表: 已经发表啦，开心, beContent=爱睡觉的小妖精uhh 2020-04-30 00:00:00 发表: 已经发表啦，开心, objectType=tool_impact_factor, channel=null, level=null, likeNumber=133, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/06/21/141c3b405ac632875dc5e2f757c9755d.jpg, createdBy=d8912207664, createdName=1085404196_71099776, createdTime=Sat May 02 00:00:00 CST 2020, time=2020-05-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2159028, encodeId=b8572159028f8, content=审稿速度:1.0 偏重的研究方向：肺癌 经验分享：个案 2天被拒枯了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=41, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=0dad8612290, createdName=ms9000001053108898, createdTime=Fri Sep 22 01:20:26 CST 2023, time=2023-09-22, status=1, ipAttribution=甘肃省), GetPortalCommentsPageByObjectIdResponse(id=2145118, encodeId=71e0214511808, content=最近还收meta分析吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=49, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=16686542389, createdName=ms7000001609282445, createdTime=Tue Jun 27 23:07:03 CST 2023, time=2023-06-27, status=1, ipAttribution=山东省), GetPortalCommentsPageByObjectIdResponse(id=2129414, encodeId=7b422129414fc, content=Submissions will be subject to an APC if accepted and published in the journal: $2750 USD / £1850 GBP / €2500 EUR, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=41, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=81ca5454976, createdName=ms3000001340442240, createdTime=Sun Apr 30 12:52:16 CST 2023, time=2023-04-30, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2117650, encodeId=032e211e650b5, content=审稿速度:1.0 经验分享：我投的生信，做了验证，第二天就拒了，感觉这个杂志应该不好中的，质量不错的。看了一下近一年这个杂志发的生信，大部分好像都是有细胞实验的。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=42, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=99d78274978, createdName=ms3000001126828781, createdTime=Sun Mar 05 09:55:55 CST 2023, time=2023-03-05, status=1, ipAttribution=广西), GetPortalCommentsPageByObjectIdResponse(id=2116294, encodeId=5621211629450, content=偏重的研究方向：肺癌;肿瘤 经验分享：投的meta分析，3天被拒, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20230223/3495061b3fd940bfae63e19d5c634f3e/4aae1a7e9e5c4f4f890a29ff7266640b.jpg, createdBy=0b086152617, createdName=兔兔好运发paper, createdTime=Fri Feb 24 16:06:22 CST 2023, time=2023-02-24, status=1, ipAttribution=四川省)]

2021-12-29 msSSSSSD

为什么期刊要求用三线表/使用三线表的意义何在？

77 1

展开1条回复

[GetPortalCommentsPageByObjectIdResponse(id=1104618, encodeId=c5ee1104618ee, content=什么时候使用柱状图，什么时候使用折线图？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=68, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=71734776539, createdName=MS54455111222, createdTime=Wed Dec 29 14:52:52 CST 2021, time=2021-12-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1104617, encodeId=94ce110461e91, content=为什么期刊要求用三线表/使用三线表的意义何在？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=77, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210511/ddebdec707734c8390a07bd0c1048717/cc11caf5d607430e9f4ca556fed68ab1.jpg, createdBy=2c4d5497888, createdName=msSSSSSD, createdTime=Wed Dec 29 14:52:52 CST 2021, time=2021-12-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=572184, encodeId=0afb5e21844d, content=请问，食管肿瘤偏内科治疗的个案能发这个杂志吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=151, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=28de5119650, createdName=14631f28m76(暂无昵称), createdTime=Wed Jun 12 18:23:00 CST 2019, time=2019-06-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=897408, encodeId=d6a789e40815, content=只能一个通讯作者吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=99, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=76105326500, createdName=148bd578m47暂无昵称, createdTime=Fri Nov 06 21:22:46 CST 2020, time=2020-11-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=590132, encodeId=c321590132ed, content=请问你的文章是基础的还是临床的呀爱睡觉的小妖精uhh 2020-04-30 00:00:00 发表: 已经发表啦，开心, beContent=爱睡觉的小妖精uhh 2020-04-30 00:00:00 发表: 已经发表啦，开心, objectType=tool_impact_factor, channel=null, level=null, likeNumber=133, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/06/21/141c3b405ac632875dc5e2f757c9755d.jpg, createdBy=d8912207664, createdName=1085404196_71099776, createdTime=Sat May 02 00:00:00 CST 2020, time=2020-05-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2159028, encodeId=b8572159028f8, content=审稿速度:1.0 偏重的研究方向：肺癌 经验分享：个案 2天被拒枯了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=41, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=0dad8612290, createdName=ms9000001053108898, createdTime=Fri Sep 22 01:20:26 CST 2023, time=2023-09-22, status=1, ipAttribution=甘肃省), GetPortalCommentsPageByObjectIdResponse(id=2145118, encodeId=71e0214511808, content=最近还收meta分析吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=49, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=16686542389, createdName=ms7000001609282445, createdTime=Tue Jun 27 23:07:03 CST 2023, time=2023-06-27, status=1, ipAttribution=山东省), GetPortalCommentsPageByObjectIdResponse(id=2129414, encodeId=7b422129414fc, content=Submissions will be subject to an APC if accepted and published in the journal: $2750 USD / £1850 GBP / €2500 EUR, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=41, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=81ca5454976, createdName=ms3000001340442240, createdTime=Sun Apr 30 12:52:16 CST 2023, time=2023-04-30, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2117650, encodeId=032e211e650b5, content=审稿速度:1.0 经验分享：我投的生信，做了验证，第二天就拒了，感觉这个杂志应该不好中的，质量不错的。看了一下近一年这个杂志发的生信，大部分好像都是有细胞实验的。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=42, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=99d78274978, createdName=ms3000001126828781, createdTime=Sun Mar 05 09:55:55 CST 2023, time=2023-03-05, status=1, ipAttribution=广西), GetPortalCommentsPageByObjectIdResponse(id=2116294, encodeId=5621211629450, content=偏重的研究方向：肺癌;肿瘤 经验分享：投的meta分析，3天被拒, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20230223/3495061b3fd940bfae63e19d5c634f3e/4aae1a7e9e5c4f4f890a29ff7266640b.jpg, createdBy=0b086152617, createdName=兔兔好运发paper, createdTime=Fri Feb 24 16:06:22 CST 2023, time=2023-02-24, status=1, ipAttribution=四川省)]

2019-06-12 14631f28m76(暂无昵称)

请问，食管肿瘤偏内科治疗的个案能发这个杂志吗？

151 1

展开1条回复

[GetPortalCommentsPageByObjectIdResponse(id=1104618, encodeId=c5ee1104618ee, content=什么时候使用柱状图，什么时候使用折线图？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=68, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=71734776539, createdName=MS54455111222, createdTime=Wed Dec 29 14:52:52 CST 2021, time=2021-12-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1104617, encodeId=94ce110461e91, content=为什么期刊要求用三线表/使用三线表的意义何在？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=77, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210511/ddebdec707734c8390a07bd0c1048717/cc11caf5d607430e9f4ca556fed68ab1.jpg, createdBy=2c4d5497888, createdName=msSSSSSD, createdTime=Wed Dec 29 14:52:52 CST 2021, time=2021-12-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=572184, encodeId=0afb5e21844d, content=请问，食管肿瘤偏内科治疗的个案能发这个杂志吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=151, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=28de5119650, createdName=14631f28m76(暂无昵称), createdTime=Wed Jun 12 18:23:00 CST 2019, time=2019-06-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=897408, encodeId=d6a789e40815, content=只能一个通讯作者吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=99, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=76105326500, createdName=148bd578m47暂无昵称, createdTime=Fri Nov 06 21:22:46 CST 2020, time=2020-11-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=590132, encodeId=c321590132ed, content=请问你的文章是基础的还是临床的呀爱睡觉的小妖精uhh 2020-04-30 00:00:00 发表: 已经发表啦，开心, beContent=爱睡觉的小妖精uhh 2020-04-30 00:00:00 发表: 已经发表啦，开心, objectType=tool_impact_factor, channel=null, level=null, likeNumber=133, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/06/21/141c3b405ac632875dc5e2f757c9755d.jpg, createdBy=d8912207664, createdName=1085404196_71099776, createdTime=Sat May 02 00:00:00 CST 2020, time=2020-05-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2159028, encodeId=b8572159028f8, content=审稿速度:1.0 偏重的研究方向：肺癌 经验分享：个案 2天被拒枯了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=41, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=0dad8612290, createdName=ms9000001053108898, createdTime=Fri Sep 22 01:20:26 CST 2023, time=2023-09-22, status=1, ipAttribution=甘肃省), GetPortalCommentsPageByObjectIdResponse(id=2145118, encodeId=71e0214511808, content=最近还收meta分析吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=49, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=16686542389, createdName=ms7000001609282445, createdTime=Tue Jun 27 23:07:03 CST 2023, time=2023-06-27, status=1, ipAttribution=山东省), GetPortalCommentsPageByObjectIdResponse(id=2129414, encodeId=7b422129414fc, content=Submissions will be subject to an APC if accepted and published in the journal: $2750 USD / £1850 GBP / €2500 EUR, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=41, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=81ca5454976, createdName=ms3000001340442240, createdTime=Sun Apr 30 12:52:16 CST 2023, time=2023-04-30, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2117650, encodeId=032e211e650b5, content=审稿速度:1.0 经验分享：我投的生信，做了验证，第二天就拒了，感觉这个杂志应该不好中的，质量不错的。看了一下近一年这个杂志发的生信，大部分好像都是有细胞实验的。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=42, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=99d78274978, createdName=ms3000001126828781, createdTime=Sun Mar 05 09:55:55 CST 2023, time=2023-03-05, status=1, ipAttribution=广西), GetPortalCommentsPageByObjectIdResponse(id=2116294, encodeId=5621211629450, content=偏重的研究方向：肺癌;肿瘤 经验分享：投的meta分析，3天被拒, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20230223/3495061b3fd940bfae63e19d5c634f3e/4aae1a7e9e5c4f4f890a29ff7266640b.jpg, createdBy=0b086152617, createdName=兔兔好运发paper, createdTime=Fri Feb 24 16:06:22 CST 2023, time=2023-02-24, status=1, ipAttribution=四川省)]

2020-11-06 148bd578m47暂无昵称

只能一个通讯作者吗？

99 1

展开1条回复

[GetPortalCommentsPageByObjectIdResponse(id=1104618, encodeId=c5ee1104618ee, content=什么时候使用柱状图，什么时候使用折线图？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=68, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=71734776539, createdName=MS54455111222, createdTime=Wed Dec 29 14:52:52 CST 2021, time=2021-12-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1104617, encodeId=94ce110461e91, content=为什么期刊要求用三线表/使用三线表的意义何在？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=77, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210511/ddebdec707734c8390a07bd0c1048717/cc11caf5d607430e9f4ca556fed68ab1.jpg, createdBy=2c4d5497888, createdName=msSSSSSD, createdTime=Wed Dec 29 14:52:52 CST 2021, time=2021-12-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=572184, encodeId=0afb5e21844d, content=请问，食管肿瘤偏内科治疗的个案能发这个杂志吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=151, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=28de5119650, createdName=14631f28m76(暂无昵称), createdTime=Wed Jun 12 18:23:00 CST 2019, time=2019-06-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=897408, encodeId=d6a789e40815, content=只能一个通讯作者吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=99, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=76105326500, createdName=148bd578m47暂无昵称, createdTime=Fri Nov 06 21:22:46 CST 2020, time=2020-11-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=590132, encodeId=c321590132ed, content=请问你的文章是基础的还是临床的呀爱睡觉的小妖精uhh 2020-04-30 00:00:00 发表: 已经发表啦，开心, beContent=爱睡觉的小妖精uhh 2020-04-30 00:00:00 发表: 已经发表啦，开心, objectType=tool_impact_factor, channel=null, level=null, likeNumber=133, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/06/21/141c3b405ac632875dc5e2f757c9755d.jpg, createdBy=d8912207664, createdName=1085404196_71099776, createdTime=Sat May 02 00:00:00 CST 2020, time=2020-05-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2159028, encodeId=b8572159028f8, content=审稿速度:1.0 偏重的研究方向：肺癌 经验分享：个案 2天被拒枯了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=41, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=0dad8612290, createdName=ms9000001053108898, createdTime=Fri Sep 22 01:20:26 CST 2023, time=2023-09-22, status=1, ipAttribution=甘肃省), GetPortalCommentsPageByObjectIdResponse(id=2145118, encodeId=71e0214511808, content=最近还收meta分析吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=49, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=16686542389, createdName=ms7000001609282445, createdTime=Tue Jun 27 23:07:03 CST 2023, time=2023-06-27, status=1, ipAttribution=山东省), GetPortalCommentsPageByObjectIdResponse(id=2129414, encodeId=7b422129414fc, content=Submissions will be subject to an APC if accepted and published in the journal: $2750 USD / £1850 GBP / €2500 EUR, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=41, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=81ca5454976, createdName=ms3000001340442240, createdTime=Sun Apr 30 12:52:16 CST 2023, time=2023-04-30, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2117650, encodeId=032e211e650b5, content=审稿速度:1.0 经验分享：我投的生信，做了验证，第二天就拒了，感觉这个杂志应该不好中的，质量不错的。看了一下近一年这个杂志发的生信，大部分好像都是有细胞实验的。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=42, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=99d78274978, createdName=ms3000001126828781, createdTime=Sun Mar 05 09:55:55 CST 2023, time=2023-03-05, status=1, ipAttribution=广西), GetPortalCommentsPageByObjectIdResponse(id=2116294, encodeId=5621211629450, content=偏重的研究方向：肺癌;肿瘤 经验分享：投的meta分析，3天被拒, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20230223/3495061b3fd940bfae63e19d5c634f3e/4aae1a7e9e5c4f4f890a29ff7266640b.jpg, createdBy=0b086152617, createdName=兔兔好运发paper, createdTime=Fri Feb 24 16:06:22 CST 2023, time=2023-02-24, status=1, ipAttribution=四川省)]

2020-05-02 1085404196_71099776

请问你的文章是基础的还是临床的呀爱睡觉的小妖精uhh 2020-04-30 00:00:00 发表:
已经发表啦，开心

爱睡觉的小妖精uhh 2020-04-30 00:00:00 发表: 已经发表啦，开心

133 1

展开1条回复

[GetPortalCommentsPageByObjectIdResponse(id=1104618, encodeId=c5ee1104618ee, content=什么时候使用柱状图，什么时候使用折线图？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=68, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=71734776539, createdName=MS54455111222, createdTime=Wed Dec 29 14:52:52 CST 2021, time=2021-12-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1104617, encodeId=94ce110461e91, content=为什么期刊要求用三线表/使用三线表的意义何在？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=77, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210511/ddebdec707734c8390a07bd0c1048717/cc11caf5d607430e9f4ca556fed68ab1.jpg, createdBy=2c4d5497888, createdName=msSSSSSD, createdTime=Wed Dec 29 14:52:52 CST 2021, time=2021-12-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=572184, encodeId=0afb5e21844d, content=请问，食管肿瘤偏内科治疗的个案能发这个杂志吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=151, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=28de5119650, createdName=14631f28m76(暂无昵称), createdTime=Wed Jun 12 18:23:00 CST 2019, time=2019-06-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=897408, encodeId=d6a789e40815, content=只能一个通讯作者吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=99, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=76105326500, createdName=148bd578m47暂无昵称, createdTime=Fri Nov 06 21:22:46 CST 2020, time=2020-11-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=590132, encodeId=c321590132ed, content=请问你的文章是基础的还是临床的呀爱睡觉的小妖精uhh 2020-04-30 00:00:00 发表: 已经发表啦，开心, beContent=爱睡觉的小妖精uhh 2020-04-30 00:00:00 发表: 已经发表啦，开心, objectType=tool_impact_factor, channel=null, level=null, likeNumber=133, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/06/21/141c3b405ac632875dc5e2f757c9755d.jpg, createdBy=d8912207664, createdName=1085404196_71099776, createdTime=Sat May 02 00:00:00 CST 2020, time=2020-05-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2159028, encodeId=b8572159028f8, content=审稿速度:1.0 偏重的研究方向：肺癌 经验分享：个案 2天被拒枯了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=41, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=0dad8612290, createdName=ms9000001053108898, createdTime=Fri Sep 22 01:20:26 CST 2023, time=2023-09-22, status=1, ipAttribution=甘肃省), GetPortalCommentsPageByObjectIdResponse(id=2145118, encodeId=71e0214511808, content=最近还收meta分析吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=49, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=16686542389, createdName=ms7000001609282445, createdTime=Tue Jun 27 23:07:03 CST 2023, time=2023-06-27, status=1, ipAttribution=山东省), GetPortalCommentsPageByObjectIdResponse(id=2129414, encodeId=7b422129414fc, content=Submissions will be subject to an APC if accepted and published in the journal: $2750 USD / £1850 GBP / €2500 EUR, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=41, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=81ca5454976, createdName=ms3000001340442240, createdTime=Sun Apr 30 12:52:16 CST 2023, time=2023-04-30, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2117650, encodeId=032e211e650b5, content=审稿速度:1.0 经验分享：我投的生信，做了验证，第二天就拒了，感觉这个杂志应该不好中的，质量不错的。看了一下近一年这个杂志发的生信，大部分好像都是有细胞实验的。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=42, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=99d78274978, createdName=ms3000001126828781, createdTime=Sun Mar 05 09:55:55 CST 2023, time=2023-03-05, status=1, ipAttribution=广西), GetPortalCommentsPageByObjectIdResponse(id=2116294, encodeId=5621211629450, content=偏重的研究方向：肺癌;肿瘤 经验分享：投的meta分析，3天被拒, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20230223/3495061b3fd940bfae63e19d5c634f3e/4aae1a7e9e5c4f4f890a29ff7266640b.jpg, createdBy=0b086152617, createdName=兔兔好运发paper, createdTime=Fri Feb 24 16:06:22 CST 2023, time=2023-02-24, status=1, ipAttribution=四川省)]

2023-09-22 ms9000001053108898 来自甘肃省

审稿速度:1.0
偏重的研究方向：肺癌
经验分享：个案 2天被拒枯了

41 0

[GetPortalCommentsPageByObjectIdResponse(id=1104618, encodeId=c5ee1104618ee, content=什么时候使用柱状图，什么时候使用折线图？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=68, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=71734776539, createdName=MS54455111222, createdTime=Wed Dec 29 14:52:52 CST 2021, time=2021-12-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1104617, encodeId=94ce110461e91, content=为什么期刊要求用三线表/使用三线表的意义何在？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=77, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210511/ddebdec707734c8390a07bd0c1048717/cc11caf5d607430e9f4ca556fed68ab1.jpg, createdBy=2c4d5497888, createdName=msSSSSSD, createdTime=Wed Dec 29 14:52:52 CST 2021, time=2021-12-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=572184, encodeId=0afb5e21844d, content=请问，食管肿瘤偏内科治疗的个案能发这个杂志吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=151, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=28de5119650, createdName=14631f28m76(暂无昵称), createdTime=Wed Jun 12 18:23:00 CST 2019, time=2019-06-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=897408, encodeId=d6a789e40815, content=只能一个通讯作者吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=99, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=76105326500, createdName=148bd578m47暂无昵称, createdTime=Fri Nov 06 21:22:46 CST 2020, time=2020-11-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=590132, encodeId=c321590132ed, content=请问你的文章是基础的还是临床的呀爱睡觉的小妖精uhh 2020-04-30 00:00:00 发表: 已经发表啦，开心, beContent=爱睡觉的小妖精uhh 2020-04-30 00:00:00 发表: 已经发表啦，开心, objectType=tool_impact_factor, channel=null, level=null, likeNumber=133, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/06/21/141c3b405ac632875dc5e2f757c9755d.jpg, createdBy=d8912207664, createdName=1085404196_71099776, createdTime=Sat May 02 00:00:00 CST 2020, time=2020-05-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2159028, encodeId=b8572159028f8, content=审稿速度:1.0 偏重的研究方向：肺癌 经验分享：个案 2天被拒枯了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=41, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=0dad8612290, createdName=ms9000001053108898, createdTime=Fri Sep 22 01:20:26 CST 2023, time=2023-09-22, status=1, ipAttribution=甘肃省), GetPortalCommentsPageByObjectIdResponse(id=2145118, encodeId=71e0214511808, content=最近还收meta分析吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=49, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=16686542389, createdName=ms7000001609282445, createdTime=Tue Jun 27 23:07:03 CST 2023, time=2023-06-27, status=1, ipAttribution=山东省), GetPortalCommentsPageByObjectIdResponse(id=2129414, encodeId=7b422129414fc, content=Submissions will be subject to an APC if accepted and published in the journal: $2750 USD / £1850 GBP / €2500 EUR, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=41, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=81ca5454976, createdName=ms3000001340442240, createdTime=Sun Apr 30 12:52:16 CST 2023, time=2023-04-30, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2117650, encodeId=032e211e650b5, content=审稿速度:1.0 经验分享：我投的生信，做了验证，第二天就拒了，感觉这个杂志应该不好中的，质量不错的。看了一下近一年这个杂志发的生信，大部分好像都是有细胞实验的。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=42, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=99d78274978, createdName=ms3000001126828781, createdTime=Sun Mar 05 09:55:55 CST 2023, time=2023-03-05, status=1, ipAttribution=广西), GetPortalCommentsPageByObjectIdResponse(id=2116294, encodeId=5621211629450, content=偏重的研究方向：肺癌;肿瘤 经验分享：投的meta分析，3天被拒, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20230223/3495061b3fd940bfae63e19d5c634f3e/4aae1a7e9e5c4f4f890a29ff7266640b.jpg, createdBy=0b086152617, createdName=兔兔好运发paper, createdTime=Fri Feb 24 16:06:22 CST 2023, time=2023-02-24, status=1, ipAttribution=四川省)]

2023-06-27 ms7000001609282445 来自山东省

最近还收meta分析吗

49 0

[GetPortalCommentsPageByObjectIdResponse(id=1104618, encodeId=c5ee1104618ee, content=什么时候使用柱状图，什么时候使用折线图？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=68, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=71734776539, createdName=MS54455111222, createdTime=Wed Dec 29 14:52:52 CST 2021, time=2021-12-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1104617, encodeId=94ce110461e91, content=为什么期刊要求用三线表/使用三线表的意义何在？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=77, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210511/ddebdec707734c8390a07bd0c1048717/cc11caf5d607430e9f4ca556fed68ab1.jpg, createdBy=2c4d5497888, createdName=msSSSSSD, createdTime=Wed Dec 29 14:52:52 CST 2021, time=2021-12-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=572184, encodeId=0afb5e21844d, content=请问，食管肿瘤偏内科治疗的个案能发这个杂志吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=151, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=28de5119650, createdName=14631f28m76(暂无昵称), createdTime=Wed Jun 12 18:23:00 CST 2019, time=2019-06-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=897408, encodeId=d6a789e40815, content=只能一个通讯作者吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=99, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=76105326500, createdName=148bd578m47暂无昵称, createdTime=Fri Nov 06 21:22:46 CST 2020, time=2020-11-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=590132, encodeId=c321590132ed, content=请问你的文章是基础的还是临床的呀爱睡觉的小妖精uhh 2020-04-30 00:00:00 发表: 已经发表啦，开心, beContent=爱睡觉的小妖精uhh 2020-04-30 00:00:00 发表: 已经发表啦，开心, objectType=tool_impact_factor, channel=null, level=null, likeNumber=133, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/06/21/141c3b405ac632875dc5e2f757c9755d.jpg, createdBy=d8912207664, createdName=1085404196_71099776, createdTime=Sat May 02 00:00:00 CST 2020, time=2020-05-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2159028, encodeId=b8572159028f8, content=审稿速度:1.0 偏重的研究方向：肺癌 经验分享：个案 2天被拒枯了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=41, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=0dad8612290, createdName=ms9000001053108898, createdTime=Fri Sep 22 01:20:26 CST 2023, time=2023-09-22, status=1, ipAttribution=甘肃省), GetPortalCommentsPageByObjectIdResponse(id=2145118, encodeId=71e0214511808, content=最近还收meta分析吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=49, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=16686542389, createdName=ms7000001609282445, createdTime=Tue Jun 27 23:07:03 CST 2023, time=2023-06-27, status=1, ipAttribution=山东省), GetPortalCommentsPageByObjectIdResponse(id=2129414, encodeId=7b422129414fc, content=Submissions will be subject to an APC if accepted and published in the journal: $2750 USD / £1850 GBP / €2500 EUR, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=41, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=81ca5454976, createdName=ms3000001340442240, createdTime=Sun Apr 30 12:52:16 CST 2023, time=2023-04-30, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2117650, encodeId=032e211e650b5, content=审稿速度:1.0 经验分享：我投的生信，做了验证，第二天就拒了，感觉这个杂志应该不好中的，质量不错的。看了一下近一年这个杂志发的生信，大部分好像都是有细胞实验的。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=42, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=99d78274978, createdName=ms3000001126828781, createdTime=Sun Mar 05 09:55:55 CST 2023, time=2023-03-05, status=1, ipAttribution=广西), GetPortalCommentsPageByObjectIdResponse(id=2116294, encodeId=5621211629450, content=偏重的研究方向：肺癌;肿瘤 经验分享：投的meta分析，3天被拒, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20230223/3495061b3fd940bfae63e19d5c634f3e/4aae1a7e9e5c4f4f890a29ff7266640b.jpg, createdBy=0b086152617, createdName=兔兔好运发paper, createdTime=Fri Feb 24 16:06:22 CST 2023, time=2023-02-24, status=1, ipAttribution=四川省)]

2023-04-30 ms3000001340442240 来自广东省

Submissions will be subject to an APC if accepted and published in the journal: $2750 USD / £1850 GBP / €2500 EUR

41 0

[GetPortalCommentsPageByObjectIdResponse(id=1104618, encodeId=c5ee1104618ee, content=什么时候使用柱状图，什么时候使用折线图？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=68, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=71734776539, createdName=MS54455111222, createdTime=Wed Dec 29 14:52:52 CST 2021, time=2021-12-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1104617, encodeId=94ce110461e91, content=为什么期刊要求用三线表/使用三线表的意义何在？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=77, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210511/ddebdec707734c8390a07bd0c1048717/cc11caf5d607430e9f4ca556fed68ab1.jpg, createdBy=2c4d5497888, createdName=msSSSSSD, createdTime=Wed Dec 29 14:52:52 CST 2021, time=2021-12-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=572184, encodeId=0afb5e21844d, content=请问，食管肿瘤偏内科治疗的个案能发这个杂志吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=151, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=28de5119650, createdName=14631f28m76(暂无昵称), createdTime=Wed Jun 12 18:23:00 CST 2019, time=2019-06-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=897408, encodeId=d6a789e40815, content=只能一个通讯作者吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=99, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=76105326500, createdName=148bd578m47暂无昵称, createdTime=Fri Nov 06 21:22:46 CST 2020, time=2020-11-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=590132, encodeId=c321590132ed, content=请问你的文章是基础的还是临床的呀爱睡觉的小妖精uhh 2020-04-30 00:00:00 发表: 已经发表啦，开心, beContent=爱睡觉的小妖精uhh 2020-04-30 00:00:00 发表: 已经发表啦，开心, objectType=tool_impact_factor, channel=null, level=null, likeNumber=133, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/06/21/141c3b405ac632875dc5e2f757c9755d.jpg, createdBy=d8912207664, createdName=1085404196_71099776, createdTime=Sat May 02 00:00:00 CST 2020, time=2020-05-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2159028, encodeId=b8572159028f8, content=审稿速度:1.0 偏重的研究方向：肺癌 经验分享：个案 2天被拒枯了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=41, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=0dad8612290, createdName=ms9000001053108898, createdTime=Fri Sep 22 01:20:26 CST 2023, time=2023-09-22, status=1, ipAttribution=甘肃省), GetPortalCommentsPageByObjectIdResponse(id=2145118, encodeId=71e0214511808, content=最近还收meta分析吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=49, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=16686542389, createdName=ms7000001609282445, createdTime=Tue Jun 27 23:07:03 CST 2023, time=2023-06-27, status=1, ipAttribution=山东省), GetPortalCommentsPageByObjectIdResponse(id=2129414, encodeId=7b422129414fc, content=Submissions will be subject to an APC if accepted and published in the journal: $2750 USD / £1850 GBP / €2500 EUR, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=41, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=81ca5454976, createdName=ms3000001340442240, createdTime=Sun Apr 30 12:52:16 CST 2023, time=2023-04-30, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2117650, encodeId=032e211e650b5, content=审稿速度:1.0 经验分享：我投的生信，做了验证，第二天就拒了，感觉这个杂志应该不好中的，质量不错的。看了一下近一年这个杂志发的生信，大部分好像都是有细胞实验的。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=42, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=99d78274978, createdName=ms3000001126828781, createdTime=Sun Mar 05 09:55:55 CST 2023, time=2023-03-05, status=1, ipAttribution=广西), GetPortalCommentsPageByObjectIdResponse(id=2116294, encodeId=5621211629450, content=偏重的研究方向：肺癌;肿瘤 经验分享：投的meta分析，3天被拒, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20230223/3495061b3fd940bfae63e19d5c634f3e/4aae1a7e9e5c4f4f890a29ff7266640b.jpg, createdBy=0b086152617, createdName=兔兔好运发paper, createdTime=Fri Feb 24 16:06:22 CST 2023, time=2023-02-24, status=1, ipAttribution=四川省)]

2023-03-05 ms3000001126828781 来自广西

审稿速度:1.0
经验分享：我投的生信，做了验证，第二天就拒了，感觉这个杂志应该不好中的，质量不错的。看了一下近一年这个杂志发的生信，大部分好像都是有细胞实验的。

42 0

[GetPortalCommentsPageByObjectIdResponse(id=1104618, encodeId=c5ee1104618ee, content=什么时候使用柱状图，什么时候使用折线图？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=68, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=71734776539, createdName=MS54455111222, createdTime=Wed Dec 29 14:52:52 CST 2021, time=2021-12-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1104617, encodeId=94ce110461e91, content=为什么期刊要求用三线表/使用三线表的意义何在？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=77, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210511/ddebdec707734c8390a07bd0c1048717/cc11caf5d607430e9f4ca556fed68ab1.jpg, createdBy=2c4d5497888, createdName=msSSSSSD, createdTime=Wed Dec 29 14:52:52 CST 2021, time=2021-12-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=572184, encodeId=0afb5e21844d, content=请问，食管肿瘤偏内科治疗的个案能发这个杂志吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=151, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=28de5119650, createdName=14631f28m76(暂无昵称), createdTime=Wed Jun 12 18:23:00 CST 2019, time=2019-06-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=897408, encodeId=d6a789e40815, content=只能一个通讯作者吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=99, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=76105326500, createdName=148bd578m47暂无昵称, createdTime=Fri Nov 06 21:22:46 CST 2020, time=2020-11-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=590132, encodeId=c321590132ed, content=请问你的文章是基础的还是临床的呀爱睡觉的小妖精uhh 2020-04-30 00:00:00 发表: 已经发表啦，开心, beContent=爱睡觉的小妖精uhh 2020-04-30 00:00:00 发表: 已经发表啦，开心, objectType=tool_impact_factor, channel=null, level=null, likeNumber=133, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/06/21/141c3b405ac632875dc5e2f757c9755d.jpg, createdBy=d8912207664, createdName=1085404196_71099776, createdTime=Sat May 02 00:00:00 CST 2020, time=2020-05-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2159028, encodeId=b8572159028f8, content=审稿速度:1.0 偏重的研究方向：肺癌 经验分享：个案 2天被拒枯了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=41, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=0dad8612290, createdName=ms9000001053108898, createdTime=Fri Sep 22 01:20:26 CST 2023, time=2023-09-22, status=1, ipAttribution=甘肃省), GetPortalCommentsPageByObjectIdResponse(id=2145118, encodeId=71e0214511808, content=最近还收meta分析吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=49, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=16686542389, createdName=ms7000001609282445, createdTime=Tue Jun 27 23:07:03 CST 2023, time=2023-06-27, status=1, ipAttribution=山东省), GetPortalCommentsPageByObjectIdResponse(id=2129414, encodeId=7b422129414fc, content=Submissions will be subject to an APC if accepted and published in the journal: $2750 USD / £1850 GBP / €2500 EUR, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=41, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=81ca5454976, createdName=ms3000001340442240, createdTime=Sun Apr 30 12:52:16 CST 2023, time=2023-04-30, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2117650, encodeId=032e211e650b5, content=审稿速度:1.0 经验分享：我投的生信，做了验证，第二天就拒了，感觉这个杂志应该不好中的，质量不错的。看了一下近一年这个杂志发的生信，大部分好像都是有细胞实验的。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=42, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=99d78274978, createdName=ms3000001126828781, createdTime=Sun Mar 05 09:55:55 CST 2023, time=2023-03-05, status=1, ipAttribution=广西), GetPortalCommentsPageByObjectIdResponse(id=2116294, encodeId=5621211629450, content=偏重的研究方向：肺癌;肿瘤 经验分享：投的meta分析，3天被拒, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20230223/3495061b3fd940bfae63e19d5c634f3e/4aae1a7e9e5c4f4f890a29ff7266640b.jpg, createdBy=0b086152617, createdName=兔兔好运发paper, createdTime=Fri Feb 24 16:06:22 CST 2023, time=2023-02-24, status=1, ipAttribution=四川省)]

2023-02-24 兔兔好运发paper 来自四川省

偏重的研究方向：肺癌;肿瘤
经验分享：投的meta分析，3天被拒

0 0

内科

外科

专科科室

热点

按科室浏览

临床工具

科研工具

其他工具

科研数智化

真实世界研究解决方案

数字化学术传播解决方案

其它

期刊讨论

科室

工具

服务